Morningstar Non-GAAP EPS of $3.48 beats by $0.44, revenue of $672.1M beats by $7.35M (MORN:NASDAQ)

Morningstar reported Q3 Non-GAAP EPS of $3.48, exceeding estimates by $0.44. Revenue reached $672.1M, up 8.9% year-over-year and $7.35M above expectations. Organic revenue grew 6.8%, or 7.8% excluding product sunsetting impacts, according to the company.

Original reporting
Published Oct 28, 2026, 8:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MORN
Bullish
high confidence
Mentioned
$MORN
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$MORNBullishHigh
01

Why it matters

The earnings beat could trigger short‑term buying pressure and may influence analyst revisions.

02

Market read

Earnings surprise provides a fresh catalyst for traders and may affect related data‑service stocks.

03

What to watch

Potential headwinds from product sunsetting could temper long‑term outlook.

Relevance 7/10Novelty 8/10Timing: after-hours release

Background

Morningstar is a provider of independent investment research and data services.

Company-level read

Ticker impact

$MORNBullishHigh confidence
Context

Morningstar reported Q3 Non-GAAP EPS of $3.48, beating estimates by $0.44 and revenue of $672.1M, beating by $7.35M.

Expected impact

likely upward pressure as the market prices in the earnings beat.

Evidence & confidence

The beat is material and fresh, providing a clear catalyst for short-term buying.

Market effects

Positive earnings may lift the financial data services sector.

U.S. market may see modest gains in related analytics stocks.

Limited to investors tracking U.S. earnings.

Counterpoint

Some analysts may view the modest revenue beat as insufficient given growth expectations.

Key entities

  • Morningstar Inc.

    Provider of investment research and data services.

Related articles

$MORNMed

Morningstar, Inc. Reports Third-Quarter 2026 Financial Results

Morningstar, Inc. (MORN) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release 22 West Washington Street Telephone: +1 312 696-6000 Chicago Facsimile: +1 312 696-6009 Illinois 60602 FOR IMMEDIATE RELEASE Morningstar, Inc. Reports Third-Quarter 2026 Financial Results CHICAGO, Oct. 28, 2026 - Morningstar, Inc. (Nasdaq: MORN) reported growth in re

$MORNMed

Profit per share rose 41% at Morningstar to $3.06 in Q3.

Morningstar reported a 41% increase in Q3 profit per share to $3.06, with revenue up 8.9% to $672.1M. CEO Kunal Kapoor highlighted product enhancements and strong adoption of AI-driven tools. Year-to-date revenue rose 9.7% to $2.0B, with net income per share up 41.6% to $8.61. The company repurchased $100M in shares during Q3 and $500M year-to-date.

High

SPCX Stock Jumps 10% Premarket: Morningstar Boosts SpaceX’s Fair Value As Starship And Orbital AI Offer Long-Term Upside

SpaceX (SPCX) stock rose 10% premarket after Morningstar increased its fair value estimate to $70 from $62, citing Starship reusability and orbital AI potential. Analyst Nicolas Owens highlighted SpaceX's strong market position, high launch volume, and cost advantages. CEO Elon Musk projected $1T revenue by 2028, up from prior estimates. Retail sentiment turned 'extremely bullish'. SPCX is down 8% YTD.

$DKNGMed

Morningstar: DraftKings Trading Well Below Fair Value Estimate

DraftKings (DKNG) shares are down 40% YTD, but Morningstar analyst Dan Wasiolek argues the stock is undervalued, with a $39 fair value estimate. Despite regulatory uncertainty, Morningstar rates it five stars, forecasting 8.1% sales and 24.9% EBITDA growth from 2026-2035. The NBA's crackdown on player proposition markets is not expected to hinder sports betting demand.